http://orcid.org/0000-0001-5381-9878
Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Timothy Fullam, Carmel Armon, Paul Barkhaus, Benjamin Barnes, Morgan Beauchamp, Michael Benatar, Tulio Bertorini, Robert Bowser, Mark Bromberg, Javier Mascias Cadavid, Gregory T. Carter, Mazen Dimachkie, Dave Ennist, Eva L. Feldman, Terry Heiman-patterson, Sartaj Jhooty, Isaac Lund, Christopher Mcdermott, Gary Pattee, Dylan Ratner, Paul Wicks & Richard Bedlack. (2023) ALSUntangled # 69: astaxanthin. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 553-557.
Read now
Read now
Yuyao Sun, Paul Barkhaus, Benjamin Barnes, Morgan Beauchamp, Michael Benatar, Tulio Bertorini, Mark Bromberg, Gregory T. Carter, Jesse Crayle, Merit Cudkowicz, Mazen Dimachkie, Eva L. Feldman, Timothy Fullam, Terry Heiman-Patterson, Sartaj Jhooty, Isaac Lund, Christopher Mcdermott, Gary Pattee, Kaitlyn Pierce, Dylan Ratner, Paul Wicks & Richard Bedlack. (2023) ALSUntangled #68: ozone therapy. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 548-552.
Read now
Read now
J. Crayle, M. Lutz, J. Raymond, P. Mehta & R. Bedlack. (2023) Study of “ALS reversals”: LifeTime environmental exposures (StARLiTE). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 54-62.
Read now
Read now
Yuyao Sun, Richard Bedlack, Carmel Armon, Morgan Beauchamp, Tulio Bertorini, Robert Bowser, Mark Bromberg, James Caress, Gregory Carter, Jesse Crayle, Merit E. Cudkowicz, Jonathan D. Glass, Carlayne Jackson, Isaac Lund, Sarah Martin, Sabrina Paganoni, Gary Pattee, Dylan Ratner, Kristiana Salmon & Paul Wicks. (2022) ALSUntangled #64: butyrates. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 638-643.
Read now
Read now
Jaap N.E. Bakers, Adriaan D. de Jongh, Tommy M. Bunte, Lindsay Kendall, Steve S. Han, Noam Epstein, Arseniy Lavrov, Anita Beelen, Johanna M.A. Visser-Meily, Leonard H. van den Berg & Ruben P. A. van Eijk. (2022) Using the ALSFRS-R in multicentre clinical trials for amyotrophic lateral sclerosis: potential limitations in current standard operating procedures. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 500-507.
Read now
Read now
Emmeline Lagrange, Elisa de la Cruz, Florence Esselin, Jean-Paul Vernoux, Nicolas Pageot, Guillaume Taieb & William Camu. (2022) Reversible sub-acute motor neuron syndrome after mushroom intoxication masquerading as amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 496-499.
Read now
Read now
Susama Verma, Jungjae Lim, Teaghen Buscemi-Kimmins & Steven W. Brose. (2022) Isolated pulmonary recovery in a veteran with late stage bulbar ALS following edaravone treatment and cessation. The Journal of Spinal Cord Medicine 45:4, pages 638-642.
Read now
Read now
Richard Bedlack, Paul Barkhaus, Greg Carter, Jesse Crayle, Christopher Mcdermott, Gary Pattee, Meraida Polak, Kristiana Salmon & Paul Wicks. (2022) ALSUntangled #62: vitamin C. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 476-479.
Read now
Read now
. (2022) ALSUntangled #61: melatonin. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:1-2, pages 157-160.
Read now
Read now
. (2021) ALSUntangled 58: Azathioprine. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 592-594.
Read now
Read now
Marlena Wosiski-Kuhn, James B. Caress, Michael S. Cartwright, Gregory A. Hawkins & Carol Milligan. (2021) Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 248-259.
Read now
Read now
Bedlack Richard. (2021) ALSUntangled 55: vitamin E (α-tocopherol). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 154-160.
Read now
Read now
John R. Bach, Giulio Chiarello, William Weiss & Nizar Souayah. (2021) Is there value in using randomized placebo controlled trials in neuromuscular disease?. Expert Review of Neurotherapeutics 21:1, pages 5-7.
Read now
Read now
Pamela A. McCombe, Fleur C Garton, Matthew Katz, Naomi R Wray & Robert D Henderson. (2020) What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?. Expert Review of Neurotherapeutics 20:9, pages 921-941.
Read now
Read now
. (2020) ALSUntangled 53: Carnitine supplements. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:5-6, pages 477-483.
Read now
Read now
. (2020) ALSUntangled No. 54: “LEAP2BFIT”. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 314-319.
Read now
Read now
. (2020) ALSUntangled No. 52: Glutathione. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 154-157.
Read now
Read now
. (2019) ALSUntangled no. 49: resveratrol. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:7-8, pages 619-624.
Read now
Read now
Articles from other publishers (13)
Michael Benatar, Stephen A Goutman, Kim A Staats, Eva L Feldman, Marc Weisskopf, Evelyn Talbott, Kuldip D Dave, Neil M Thakur & Ammar Al-Chalabi. (2023) A roadmap to ALS prevention: strategies and priorities. Journal of Neurology, Neurosurgery & Psychiatry 94:5, pages 399-402.
Crossref
Crossref
Yan Qi, Chen Yang, Hui Zhao, Zhanjin Deng, Jin Xu, Weijing Liang, Zhitang Sun & John Dirk Vestergaard Nieland. (2022) Neuroprotective Effect of Sonic Hedgehog Mediated PI3K/AKT Pathway in Amyotrophic Lateral Sclerosis Model Mice. Molecular Neurobiology 59:11, pages 6971-6982.
Crossref
Crossref
Nan Hu, Dongchao Shen, Xunzhe Yang, Liying Cui & Mingsheng Liu. (2022) Plateaus and reversals evaluated by different methods in patients with limb-onset amyotrophic lateral sclerosis. Journal of Clinical Neuroscience 97, pages 93-98.
Crossref
Crossref
Paola Ruffo, Claudia Strafella, Raffaella Cascella, Valerio Caputo, Francesca Luisa Conforti, Sebastiano Andò & Emiliano Giardina. (2021) Deregulation of ncRNA in Neurodegenerative Disease: Focus on circRNA, lncRNA and miRNA in Amyotrophic Lateral Sclerosis. Frontiers in Genetics 12.
Crossref
Crossref
Shu-Hui Xie, Hui Li, Jing-Jing Jiang, Yuan Quan & Hong-Yu Zhang. (2021) Multi-Omics Interpretation of Anti-Aging Mechanisms for ω-3 Fatty Acids. Genes 12:11, pages 1691.
Crossref
Crossref
Sebastian Jugl, Aimalohi Okpeku, Brianna Costales, Earl J. Morris, Golnoosh Alipour-Haris, Juan M. Hincapie-Castillo, Nichole E. Stetten, Ruba Sajdeya, Shailina Keshwani, Verlin Joseph, Yahan Zhang, Yun Shen, Lauren Adkins, Almut G. Winterstein & Amie Goodin. (2021) A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019. Medical Cannabis and Cannabinoids 4:1, pages 21-42.
Crossref
Crossref
Michael S. Bereman, Kaylie I. Kirkwood, Tharani Sabaretnam, Sarah Furlong, Dominic B. Rowe, Gilles J. Guillemin, Allyson L. Mellinger & David C. Muddiman. (2020)
Metabolite Profiling Reveals Predictive Biomarkers and the Absence of β-Methyl Amino-
l
-alanine in Plasma from Individuals Diagnosed with Amyotrophic Lateral Sclerosis
. Journal of Proteome Research 19:8, pages 3276-3285.
Crossref
Crossref
B. Kuraszkiewicz, H. Goszczyńska, T. Podsiadły-Marczykowska, M. Piotrkiewicz, P. Andersen, M. Gromicho, J. Grosskreutz, M. Kuźma-Kozakiewicz, S. Petri, B. Stubbendorf, K. Szacka, H. Uysal & M. de Carvalho. (2020) Potential Preventive Strategies for Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience 14.
Crossref
Crossref
Coco Newton. 2020. Integrative and Functional Medical Nutrition Therapy. Integrative and Functional Medical Nutrition Therapy
863
912
.
Mark B. Bromberg. (2019) What Is in the Literature. Journal of Clinical Neuromuscular Disease 21:2, pages 84-89.
Crossref
Crossref
Natalia Nowicka, Jakub Juranek, Judyta K. Juranek & Joanna Wojtkiewicz. (2019) Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 20:11, pages 2616.
Crossref
Crossref
Akil I. Joseph, Paula B. Luis & Claus Schneider. (2018) A Curcumin Degradation Product, 7-Norcyclopentadione, Formed by Aryl Migration and Loss of a Carbon from the Heptadienedione Chain. Journal of Natural Products 81:12, pages 2756-2762.
Crossref
Crossref
Ellen S. Pierce. (2018) How did Lou Gehrig get Lou Gehrig’s disease? Mycobacterium avium subspecies paratuberculosis in manure, soil, dirt, dust and grass and amyotrophic lateral sclerosis (motor neurone disease) clusters in football, rugby and soccer players. Medical Hypotheses 119, pages 1-5.
Crossref
Crossref